Anzeige
Mehr »
Dienstag, 03.03.2026 - Börsentäglich über 12.000 News
Erste Psilocybin-Behandlungen laufen - warum steht Optimi noch bei Pennystock-Level?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40RA7 | ISIN: CA2059531020 | Ticker-Symbol: YU1
Frankfurt
02.03.26 | 15:10
0,266 Euro
+46,15 % +0,084
1-Jahres-Chart
CONAVI MEDICAL CORP Chart 1 Jahr
5-Tage-Chart
CONAVI MEDICAL CORP 5-Tage-Chart
RealtimeGeldBriefZeit
0,1060,35402.03.

Aktuelle News zur CONAVI MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoConavi Medical Corp. reports Q1 results1
DoConavi Medical Corp.: Conavi Medical Reports Fiscal First Quarter 2026 Results and Operational Highlights118- Successfully Closes $12M Public Offering, Strengthens Balance Sheet and Supports Anticipated U.S. Launch- Recent Peer-Reviewed Publication Demonstrates Advantages of Hybrid IVUS-OCT Imaging TORONTO...
► Artikel lesen
13.02.Conavi Medical Corp: Conavi highlights hybrid IVUS-OCT study results1
13.02.Conavi Medical Corp.: Conavi Medical Highlights Peer-Reviewed Publication Demonstrating Advantages of Hybrid IVUS-OCT Imaging1
14.01.Conavi Medical Corp: Conavi Medical closes $12-million public offering1
13.01.Conavi Medical Corp. Announces Closing of $12M Public Offering170NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) ("Conavi" or the "Company"),...
► Artikel lesen
CONAVI MEDICAL Aktie jetzt für 0€ handeln
08.01.Conavi Medical Corp: Conavi files amended final prospectus2
08.01.Conavi Medical Corp. Announces Filing of Amended & Restated Final Prospectus1
30.12.25Conavi Medical GAAP EPS of -C$0.36, revenue of C$9.1M2
29.12.25Conavi Medical Corp.: Conavi Medical Reports Fiscal Year 2025 Results and Operational Highlights245Next-Generation Novasight Hybrid System Submitted to U.S. FDA for 510(k) Clearance U.S. and European Class 1A Guidelines Reinforce Growing Adoption of Image-Guided PCIPeer-Reviewed Publications Highlight...
► Artikel lesen
18.12.25Conavi Medical Corp. Announces Pricing of Public Offering of Common Shares and/or Pre-Funded Warrants1
21.11.25Conavi Medical announces public offering of common shares and pre-funded warrants1
21.11.25Conavi Medical files preliminary prospectus for stock offering1
21.11.25Conavi Medical Corp. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants2
03.11.25Conavi Medical Corp: Conavi Medical appoints Quick as CFO2
29.10.25Conavi Medical Corp: Conavi gets Ontario funding for imaging system launch1
23.10.25Conavi Medical Corp.: Conavi Medical to Highlight Novasight Hybrid Imaging at TCT 20252
23.10.25Conavi Medical Corp: Conavi Medical best efforts prospectus offering1
16.10.25Conavi Medical Corp.: Conavi Medical to Present at the Planet MicroCap Showcase: TORONTO in partnership with MicroCapClub on Wednesday, October 22, 20251
16.09.25Conavi Medical Corp: Conavi submits Novasight imaging system to FDA1
Weiter >>
27 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1